Evidence map›Paper›PMID 38074677›Full record

ArticleFrontiers in oncology2023

Differentiation between small hepatocellular carcinoma (<3 cm) and benign hepatocellular lesions in patients with Budd-Chiari syndrome: the role of multiparametric MR imaging.

Ghazal Zandieh, Haneyeh Shahbazian, Hao Tang, Qingxia Wu, Mohammadreza Shaghaghi, Bita Hazhirkarzar, Azarakhsh Baghdadi, Shadi Afyouni, Franco Verde, Timothy Pawlik and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Ghazal ZandiehJohns Hopkins Medicine, Johns Hopkins University, Baltimore, MD, United States.
Haneyeh ShahbazianThe Johns Hopkins Hospital, Johns Hopkins Medicine, Baltimore, MD, United States.
Hao TangJohns Hopkins Medicine, Johns Hopkins University, Baltimore, MD, United States.
Qingxia WuThe Johns Hopkins Hospital, Johns Hopkins Medicine, Baltimore, MD, United States.
Mohammadreza ShaghaghiThe Johns Hopkins Hospital, Johns Hopkins Medicine, Baltimore, MD, United States.
Bita HazhirkarzarThe Johns Hopkins Hospital, Johns Hopkins Medicine, Baltimore, MD, United States.
Azarakhsh BaghdadiThe Johns Hopkins Hospital, Johns Hopkins Medicine, Baltimore, MD, United States.
Shadi AfyouniThe Johns Hopkins Hospital, Johns Hopkins Medicine, Baltimore, MD, United States.
Franco VerdeThe Johns Hopkins Hospital, Johns Hopkins Medicine, Baltimore, MD, United States.
Timothy PawlikDepartment of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, United States.
Ihab KamelThe Johns Hopkins Hospital, Johns Hopkins Medicine, Baltimore, MD, United States.
Johns Hopkins Medicine · USJohns Hopkins University · USJohns Hopkins Hospital · USThe Ohio State University Wexner Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To investigate the value of multiparametric MR imaging to differentiate between small hepatocellular carcinoma (s-HCC) versus benign liver lesions in patients with Budd-Chiari syndrome. Methods: 12 patients with benign hepatocellular lesions and 32 patients with small (<3 cm) HCCs were assessed. MRI images were reviewed by two radiologists blinded to the patient background information; lesion T1 and T2 signal intensities and ADC values were compared with the background liver. Enhancement of lesion relative to hepatic parenchyma [(T1 Results: There were consistent differences in T1 Conclusion: Multiparametric MR imaging is a useful method to help differentiate benign liver lesions from sHCC in patients with Budd-Chiari syndrome.

Indexed as

benign hepatocellular lesionsBudd-Chiari syndromedysplastic noduleMRIsmall hepatocellular carcinoma

Identifiers

PMID38074677
PMCPMC10703288
OpenAlexW4388940245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.